Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase 1 (Cdk1), formerly called Cdc2 (or p34(Cdc2)), interacts with cyclin B1 to form an active heterodimer. The activity of Cdk1 is subjected to a complex spatiotemporary regulation, required to guarantee its scheduled contribution to the mitotic prophase and metaphase. Moreover, the activation of Cdk1 may be required for apoptosis induction in some particular pathways of cell killing. This applies to several clinically important settings, for instance to paclitaxel-induced killing of breast cancer cells, in which the ErbB2 receptor kinase can mediate apoptosis inhibition through inactivation of Cdk1. The activation of Cdk1 participates also in HIV-1-induced apoptosis, upstream of the p53-dependent mitochondrial permeabilization step. An unscheduled Cdk1 activation may contribute to neuronal apoptosis occurring in neurodegenerative diseases. Finally, the premature activation of Cdk1 can lead to mitotic catastrophe, for instance after irradiation-induced DNA damage. Thus, a cell type-specific modulation of Cdk1 might be taken advantage of for the therapeutic correction of pathogenic imbalances in apoptosis control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the primary alterations that drive catastrophic mitoses can originate in other phases of the cell cycles, including the S phase (e.g., a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [979]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“As shown in a phase II clinical trial, such cancers become responsive to taxol in vivo when taxol is combined with Herceptin (Trastuzumab), a humanized monoclonal anti-ErbB2 antibody.(24) In HL60 myelomonocytic leukemia cells, the taxolinduced Cdk1 activation is not affected by Bcl-2 nor is it inhibited by the pan-cas…”
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Self-citationMitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Organelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Self-citationYamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Freeman, R. S., Estus, S., & Johnson, E. M. (1994) · Neuron · doi:10.1016/0896-6273(94)90276-3 · Cited by 573
Research works printed but not linked: 1
- Zhai S, Senderowicz AM, Sausville EA, Figg WD . 2002 Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development Ann. Pharmacother. 36: 905–911 · doi:10.1345/aph.1a162 · Paper page
Cited by
Items 101–200 of 350
Zhu, S., Al‐Mathkour, M. M., Cao, L., Khalafi, S., Chen, Z., Poveda, J., Peng, D., Lu, H., Soutto, M., Hu, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112005 · Cited by 43
Hemström, T. H., Sandström, M., & Zhivotovsky, B. (2006) · International Journal of Cancer · doi:10.1002/ijc.21927 · Cited by 44
Chan, Y. W., Ma, H. T., Wong, W., Ho, C. C., On, K. F., & Poon, R. Y. C. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5880 · Cited by 44
Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium
Yazlovitskaya, E. M., Linkous, A. G., Thotala, D. K., Cuneo, K. C., & Hallahan, D. E. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.93 · Cited by 43
Guerram, M., Jiang, Z., Sun, L., Zhu, X., & Zhang, L. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.10.003 · Cited by 41
Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment
Borgne‐Sanchez, A., Versteege, I., Mahé, M. M., Studény, A., Léonce, S., Naime, I., Rodriguez, M., Hickman, J. A., Meijer, L., & Golsteyn, R. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209718 · Cited by 52
CellCycleTRACER accounts for cell cycle and volume in mass cytometry data
Rapsomaniki, M. A., Lun, X.-K., Woerner, S., Laumanns, M., Bodenmiller, B., & Martínez, M. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03005-5 · Cited by 42
Bork, U., Lee, W., Kuchler, A., Dittmar, T., & Thévenod, F. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00273.2009 · Cited by 45
Hsu, J., Chiang, P., & Guh, J. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0453-5 · Cited by 45
Tibes, R., & Bogenberger, J. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01205 · Cited by 44
Chromosome damage and progression into and through mitosis in vertebrates
Morrison, C. G., & Rieder, C. L. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.005 · Cited by 47
Zhu, L., Kandasamy, S. K., Liao, S. E., & Fukunaga, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06404-w · Cited by 40
DNA damage checkpoint execution and the rules of its disengagement
Yam, C., Lim, H. H., & Surana, U. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1020643 · Cited by 54
Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer
Bae, T., Weon, K.-Y., Lee, J., Eum, K., Kim, S., & Choi, J. W. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv140 · Cited by 46
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Karim, M. E., Tha, K. K., Othman, I., Uddin, M. B., & Chowdhury, E. H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020065 · Cited by 40
Current and Emerging Biomarkers of Cell Death in Human Disease
Li, K., Wu, D., Chen, X., Zhang, T., Zhang, L., Yi, Y., Miao, Z., Jin, N., Bi, X., Wang, H., et al. (2014) · BioMed Research International · doi:10.1155/2014/690103 · Cited by 48
Paiardini, M., Cervasi, B., Sumpter, B., McClure, H. M., Sodora, D. L., Magnani, M., Staprans, S. I., Piedimonte, G., & Silvestri, G. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.634-642.2006 · Cited by 39
Zhai, T., Zhang, X., Hei, Z., Jin, L., Han, C., Ko, A. T., Yu, X., & Wang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628621 · Cited by 46
CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
Ying, X., Che, X., Wang, J., Zou, G., Yu, Q., & Zhang, X. (2021) · Journal of Cancer · doi:10.7150/jca.51139 · Cited by 35
Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion
Santra, M., Santra, S., Roberts, C., Zhang, R. L., & Chopp, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05758.x · Cited by 41
Watanabe, G., Behrns, K. E., Kim, J., & Kim, R. D. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0888-2 · Cited by 34
Henley, D. C., Isbill, M., Fernando, R., Foster, J. S., & Wimalasena, J. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0262-1 · Cited by 35
Hub genes and key pathways of non‑small lung cancer identified using bioinformatics
Tang, Q., Zhang, H., Kong, M., Mao, X., & Cao, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.8882 · Cited by 34
Deng, J., Han, Y., Yan, C., Tian, X., Tao, J., Kang, J., & Li, S. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0434-7 · Cited by 35
Is the Rac GTPase‐activating toxin CNF1 a smart hijacker of host cell fate?
Malorni, W., & Fiorentini, C. (2006) · The FASEB Journal · doi:10.1096/fj.05-4706hyp · Cited by 34
The Cell Cycle: Accelerators, Brakes, and Checkpoints
Ivanchuk, S. M., & Rutka, J. T. (2004) · Neurosurgery · doi:10.1227/01.neu.0000109534.28063.5d · Cited by 43
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer
Musende, A. G., Eberding, A., Jia, W. W.-G., Ramsay, E., Bally, M. B., & Guns, E. T. (2010) · The Prostate · doi:10.1002/pros.21179 · Cited by 33
Natarajan, G., Ramalingam, S., Ramachandran, I., May, R. J., Queimado, L., Houchen, C. W., & Anant, S. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00037.2008 · Cited by 36
RetractedFujita, M., Yagami, T., Fujio, M., Tohji, C., Takase, K., Yamamoto, Y., Sawada, K., Yamamori, M., & Okamura, N. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.010 · Cited by 34
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Nakouzi, N. A., Wang, C. K., Beraldi, E., Jäger, W., Ettinger, S., Fazli, L., Nappi, L., Bishop, J. L., Zhang, F., Chauchereau, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506059 · Cited by 34
Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe
Chan, Y. W., Chen, Y., & Poon, R. Y. C. (2008) · Oncogene · doi:10.1038/onc.2008.369 · Cited by 32
Oridonin inhibits BxPC-3 cell growth through cell apoptosis
Xu, B., Shen, W., Liu, X., Zhang, T., Ren, J., Fan, Y., & Xu, J. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu134 · Cited by 31
Żuryń, A., Litwiniec, A., Gackowska, L., Pawlik, A., Grzanka, A. A., & Grzanka, A. (2012) · Cell Biology International · doi:10.1042/cbi20120274 · Cited by 33
Ahn, M., Kim, T., Kwon, S., Yoon, H., Kim, H. S., Kim, J., Kim, Y., Kang, K. W., Ahn, S., & Yoon, J. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.08.015 · Cited by 31
Gomez, L. A., Pozas, A. D. L., & Perez‐Stable, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0467 · Cited by 31
Li, Y., Wang, R., Ma, E., Deng, Y., Wang, X., Xiao, J., & Jing, Y. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328336b383 · Cited by 33
Wu, X., Chen, X., Jia, D. T., Cao, Y. W., Gao, S., Guo, Z., Zerbe, P., Chai, Y., Diao, Y., & Zhang, L. (2016) · Scientific Reports · doi:10.1038/srep25491 · Cited by 31
Zhang, Q., Chen, L., Gao, M., Wang, S., Meng, L., & Guo, L. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04546-6 · Cited by 31
Cozzi, M., Giorgi, F. D., Marcelli, E., Pentimalli, F., Forte, I. M., Schenone, S., D’Urso, V., Falco, G. D., Botta, M., Giordano, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19519 · Cited by 37
p53—A pro-apoptotic signal transducer involved in AIDS
Castedo, M., Perfettini, J., Piacentini, M., & Kroemer, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.188 · Cited by 31
Self-citationLv, X., Zhou, H., Hu, K., Lin, L., Yang, Y., Li, L., Tang, L. P., Huang, J., Shen, Y., Jiang, R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105838 · Cited by 30
Ashrafian, S., Zarrineh, M., Jensen, P., Nawrocki, A., Rezadoost, H., Ansari, A. M., Farahmand, L., Ghassempour, A., & Larsen, M. R. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00168 · Cited by 30
Ramalingam, S., Natarajan, G., Schafer, C., Subramaniam, D., May, R. J., Ramachandran, I., Queimado, L., Houchen, C. W., & Anant, S. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00540.2007 · Cited by 28
Torgler, R., Jakob, S., Ontsouka, E. C., Nachbur, U., Mueller, C., Green, D. R., & Brunner, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406913200 · Cited by 28
Abolmaesoomi, M., Aziz, A. A., Junit, S. M., & Ali, J. M. (2019) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2019.05.002 · Cited by 27
Glutamine synthetase facilitates cancer cells to recover from irradiation-induced G2/M arrest
Peng, Y., Fu, S., Hu, W., Qiu, Y., Zhang, L., Tan, R., & Sun, L. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1665394 · Cited by 30
Furno, D. L., Graziano, A. C. E., Caggia, S., Perrotta, R. E., Tarico, M. S., Giuffrida, R., & Cardile, V. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0830-x · Cited by 29
Byczek-Wyrostek, A., Kitel, R., Rumak, K., Skonieczna, M., Kasprzycka, A., & Walczak, K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.021 · Cited by 27
Nascimento, R., & Parkhouse, R. M. E. (2007) · Journal of General Virology · doi:10.1099/vir.0.82589-0 · Cited by 27
Bhati, R. S., Gökmen‐Polar, Y., Sledge, G. W., Fan, C., Nakshatri, H., Ketelsen, D., Borchers, C. H., Dial, M. J., Patterson, C., & Klauber‐DeMore, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3406 · Cited by 27
Tripeptidyl peptidase II in human oral squamous cell carcinoma
Usukura, K., Kasamatsu, A., Okamoto, A., Kouzu, Y., Higo, M., Koike, H., Sakamoto, Y., Ogawara, K., Shiiba, M., Tanzawa, H., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1307-y · Cited by 26
Wu, H., Li, L., Ai, Z., Yin, J., & Chen, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.9903 · Cited by 28
Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
Yang, Y., Liu, Q., Guo, X., Yuan, Q., Nian, S., Kang, P., Xu, Z., Li, L., & Ye, Y. (2022) · Journal of Oncology · doi:10.1155/2022/8115474 · Cited by 28
An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells
Cahuzac, N., Studény, A., Marshall, K. S., Versteege, I., Wetenhall, K., Pfeiffer, B., Léonce, S., Hickman, J. A., Pierré, A., & Golsteyn, R. M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.014 · Cited by 29
C/EBPβ Is a Transcriptional Regulator of Wee1 at the G2/M Phase of the Cell Cycle
Lee, J. H., Sung, J. Y., Choi, E. K., Yoon, H.-K., Kang, B., Hong, E. K., Park, B.-K., Kim, Y.-N., Rho, S. B., & Yoon, K. (2019) · Cells · doi:10.3390/cells8020145 · Cited by 24
Li, T., Xu, Y., Wang, Y., & Jiang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02040-8 · Cited by 26
Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis
Liu, W., Li, W., Fujita, T., Yang, Q., & Wan, Y. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm251 · Cited by 24
Zajac, M., Moneo, M. V., Carnero, A., Benitez, J. J., & Martínez–Delgado, B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0327 · Cited by 27
Chandrasekaran, S., & Bonchev, D. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.02.001 · Cited by 31
Yu, L., Shang, Z., Abdisalaam, S., Lee, K.-J., Gupta, A. K. D., Hsieh, J., Asaithamby, A., Chen, B. P. C., & Saha, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw746 · Cited by 25
p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription
Innocente, S. A., & Lee, J. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.028 · Cited by 29
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
Zhao, Y., & Yang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4259 · Cited by 26
Marlier, Q., Jibassia, F., Verteneuil, S., Linden, J., Kaldis, P., Meijer, L., Nguyen, L., Vandenbosch, R., & Malgrange, B. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0044-7 · Cited by 27
Leng, J., Zhao, Y., Sheng, P., Xia, Y., Chen, T., Zhao, S., Xie, S., Yan, X., Wang, X., Yin, Y., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01595 · Cited by 24
p21 Protects “Super p53” Mice from the Radiation-Induced Gastrointestinal Syndrome
Sullivan, J. M., Jeffords, L. B., Lee, C., Rodrigues, R. C., Ma, Y., & Kirsch, D. G. (2012) · Radiation Research · doi:10.1667/rr2545.1 · Cited by 23
Ren, H.-P., Yin, X.-Y., Yu, H., & Xiao, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.5744 · Cited by 29
Economopoulou, C., Pappa, V., Papageorgiou, S. G., Kontsioti, F., Economopoulou, P., Charitidou, E., Girkas, K., Kapsimali, V., Papasteriadi, C., Tsirigotis, P. D., et al. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0835-2 · Cited by 24
Chen, S., Wu, Y., Qin, X., Wen, P., Liu, J., & Yang, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113639 · Cited by 22
Afarin, R., Ahmadpour, F., Hatami, M., Monjezi, S., & Igder, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31925 · Cited by 26
Deciphering c-MYC-regulated genes in two distinct tissues
Robson, S. C., Ward, L., Brown, H. K., Turner, H., Hunter, E., Pelengaris, S., & Khan, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-476 · Cited by 23
Identification of a novel cyclin required for the intrinsic apoptosis pathway in lymphoid cells
Roig, M. B., Roset, R., Ortet, L., Balsiger, N. A., Anfosso, A., Cabellos, L., Garrido, M., Alameda, F., Brady, H. J. M., & Gil‐Gómez, G. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.145 · Cited by 23
Nie, B.-X., Zhao, G., Yuan, X.-F., Yu, L.-X., Zhang, J., Yuan, Y., Liu, Y. Z., Hu, J., Song, E., Zhou, Y., et al. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102053 · Cited by 22
Massacci, G., Venafra, V., Latini, S., Bica, V., Pugliese, G. M., Graziosi, S., Klingelhuber, F., Krahmer, N., Fischer, T., Mougiakakos, D., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01785-w · Cited by 24
Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells
Alisi, A., Mele, R., Spaziani, A., Tavolaro, S., Palescandolo, E., & Balsano, C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20363 · Cited by 21
Chang, L., Yu, Y., Liu, C., Cheng, Y., Chou, R., Hsieh, M., Lin, H.-Y., Hung, H., Huang, L.-J., Wu, Y., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2765-0 · Cited by 22
Zha, C., Deng, W., Fu, Y., Tang, S., Lan, X., Ye, Y., Su, Y., Jiang, L., Chen, Y., Huang, Y., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.022 · Cited by 22
Wang, X., Niu, J., Li, J., Shen, X., Shen, S., Straubinger, R. M., & Qu, J. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000519 · Cited by 21
Subramaniam, D., Nicholes, N. D., Dhar, A., Umar, S., Awasthi, V., Welch, D. R., Jensen, R. A., & Anant, S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0399 · Cited by 21
Zhai, T., Zhang, X., Hei, Z., Jin, L., Han, C., Ko, A. T., Yu, X., & Wang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.792330 · Cited by 21
Nandi, S., Dey, R., Dey, S., Samadder, A., & Saxena, A. K. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210908101751 · Cited by 20
Peng, C., Han, Y., Jie-Deng, Yan, C., Jiankang, Bo-Luan, & JieLi (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.100 · Cited by 20
Molecular markers in oral lichen planus: A systematic review
Sagari, S., Sanadhya, S., Doddamani, M. H., & Rajput, R. (2016) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.180964 · Cited by 23
Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer
Nguyen, L., Dobiasch, S., Schneider, G., Schmid, R. M., Azimzadeh, O., Kanev, K., Buschmann, D., Pfaffl, M. W., Bartzsch, S. H., Schmid, T. E., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.03.038 · Cited by 27
Praveenkumar, E., Gurrapu, N., Kolluri, P. K., Shivaraj, S., Subhashini, N. J. P., & Dokala, A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105377 · Cited by 21
Chen, Y.-C., Gu, Y., Hu, H., Liu, H., Li, W., Huang, C., Chen, J., Liang, L., & Liu, Y. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112134 · Cited by 18
Li, C., Elsasser, T. H., & Kahl, S. (2009) · Journal of Molecular Signaling · doi:10.1186/1750-2187-4-1 · Cited by 19
Ghrelin regulates cell cycle-related gene expression in cultured hippocampal neural stem cells
Chung, H., & Park, S. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0126 · Cited by 19
Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives
Anasamy, T., Chee, C. F., Wong, Y. F., Heh, C. H., Kiew, L. V., Lee, H. B., & Chung, L. Y. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.6089 · Cited by 21
Cell death classification: A new insight based on molecular mechanisms
Dehghan, S., Kheshtchin, N., Hassannezhad, S., & Soleimani, M. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113860 · Cited by 23
Yuan, Q., Dong, C. D., Ge, Y., Chen, X., Li, Z., Li, X., Lu, Q., Peng, F., Wu, X., Zhao, J., et al. (2019) · Aging · doi:10.18632/aging.102402 · Cited by 18
Feng, Y., Wu, J., Feng, X., Tao, D., Hu, J., Qin, J., Li, X., Xiao, W. L., Gardner, K. L., Judge, S. I. V., et al. (2007) · Oncology Reports · doi:10.3892/or.17.6.1437 · Cited by 18
Lu, P., Yu, C., Chiang, P., Chen, Y., Ho, Y., Kung, F., & Guh, J. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.07.088 · Cited by 18
Mancinelli, L., Angelis, P. M. D., Annulli, L., Padovini, V., Elgjo, K. M., & Gianfranceschi, G. L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-55 · Cited by 18
Sun, Z., Li, Y., Wang, H., Cai, M., Gao, S., Liu, J., Tong, L., Hu, Z., Wang, Y., Wang, K., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14220 · Cited by 18
Retardation of C2C12 myoblast cell proliferation by exposure to low-temperature atmospheric plasma
Nakai, N., Fujita, R., Kawano, F., Takahashi, K., Ohira, T., Shibaguchi, T., Nakata, K., & Ohira, Y. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0328-5 · Cited by 17
Strusi, G., Suelzu, C. M., Horwood, N. J., Münsterberg, A., & Bao, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1264032 · Cited by 21
Ashraf, S., Deshpande, N. R., Cheung, Q., Boakye, J., Wong, R. K., Gauthier, A. G., Parekh, M., Adhikari, Y., Melangath, G., & Jurkunas, U. V. (2024) · Communications Biology · doi:10.1038/s42003-024-07179-1 · Cited by 20
Rondini, E. A., & Bennink, M. R. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/351796 · Cited by 19
Mattila, R., Alanen, K. A., & Syrjänen, S. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00903.x · Cited by 17
Bayart, É., Grigorieva, O., Leibovitch, S. A., Onclercq, R., & Amor-Guéret, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1613 · Cited by 22
Metadata
- Authors
- Castedo, M., Perfettini, J.-L., Roumier, T., & Kroemer, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Kroemer, G
- Venue
- Cell Death & Differentiation
- Published
- 2002-12
- Volume
- 9
- Issue
- 12
- Pages
- 1287-1293
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2084337297
- Cited by
- 345
- References
- 66
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 18 · 2020: 11 · 2019: 15 · 2018: 24 · 2017: 17 · 2016: 14 · 2015: 12 · 2014: 23 · 2013: 13 · 2012: 14
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sidaction
- European Commission
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclin-dependent kinase 1, CDK1, apoptosis, mitotic catastrophe, cell cycle regulation, cyclin B1, CDK1 activation, breast cancer, ERBB2, p53, mitochondrial membrane permeabilization, neuronal apoptosis, neurodegenerative diseases, CDK1 inhibition
- MeSH terms
- Animals, DNA Damage, Eukaryotic Cells, Humans, Mitosis, HIV-1, CDC2 Protein Kinase, Apoptosis, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.